What it is
Sermorelin is a synthetic peptide consisting of the first twenty-nine amino acids of growth hormone releasing hormone (GHRH). It works by stimulating the pituitary to release the body’s own growth hormone in a more physiologic, pulsatile pattern than direct administration of recombinant growth hormone.
A historical note matters here: Sermorelin was previously available as an FDA-approved branded product (Geref), but that formulation was discontinued from the U.S. market. Today, sermorelin is prescribed as a compounded peptide sourced from licensed compounding pharmacies and used off-label under physician supervision. Patients with diagnosed growth hormone deficiency requiring formal endocrine treatment should be managed by an endocrinologist with FDA-approved recombinant growth hormone, not a compounded peptide.
How Dr. Brown approaches it
Peptide therapy at Esvie begins with a clinical consultation, not a phone order. Dr. Brown reviews your history, baseline labs where appropriate, the indication for treatment, and any contraindications before sermorelin is prescribed.
If sermorelin is appropriate, a written protocol — dose, frequency, timing, duration, and monitoring plan — is provided. Sermorelin is typically dosed before bed to align with the body’s natural overnight growth hormone pulse. Protocols generally run three to six months with structured breaks.
What to expect
Consultation: An in-person visit with Dr. Brown. Medical history, baseline labs as indicated, screening for contraindications, and a discussion of realistic outcomes.
Treatment cycle: Subcutaneous injection administered nightly. Most patients self-administer at home after instruction.
Monitoring: Check-ins through the cycle. Labs may be repeated to assess response and safety. Adjustments happen based on clinical picture.
No downtime, no aftercare: Injection sites may be mildly tender briefly; nothing more.
Candidacy
Good candidates are adults with age-related decline in the growth hormone axis or related concerns — sleep quality, recovery, body composition — that warrant physician-supervised peptide therapy.
Not a candidate if you are pregnant or nursing. Not a candidate with active untreated malignancy. Not a candidate with diagnosed growth hormone deficiency requiring formal endocrine care. Not a candidate seeking performance enhancement outside a clinical indication.
If sermorelin is not appropriate, Dr. Brown will say so and discuss alternatives — CJC-1295, lifestyle work, or referral when warranted.